The Centre proposes amendments to Rule 43A of the Drugs Rules, 1945 to expand the authorised import gateways for drugs, medical devices, and related healthcare goods. The change is aimed at making import clearances smoother and reducing logistics burdens for healthcare product shipments.

Across outlets, the core approach is the same: increase the locations where such items can enter India and improve the operational flow for importers. Business Line frames the proposal in terms of streamlining clearances and cutting logistics costs, while The Hindu emphasises easing day-to-day import operations by reducing inland transportation distances. Business Line also highlights the wider scope of Rule 43A by noting that it currently specifies entry points such as ports, airports, railway stations, and road crossings, indicating that the amendment would broaden where imports can be channelled.